Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.diabet.2021.101267 http://scihub22266oqcxt.onion/10.1016/j.diabet.2021.101267 34332112!8317499!34332112     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diabetes+Metab 2021 ; 47 (6): 101267 Nephropedia Template TP {{tp|p=34332112|t=2021. Diabetic ketoacidosis and mortality in COVID-19 infection |pdf=|usr=}}{{34332112}} gab.com Text Diabetic ketoacidosis and mortality in COVID-19 infection JO: Diabetes Metab http://www.kidney.de/pget.php?&tw=1&pmid=34332112 #FOAvip AIM: - Patients with diabetes have increased morbidity and mortality from COVID-19. Case reports describe patients with simultaneous COVID-19 and diabetic acidosis (DKA), however there is limited data on the prevalence, predictors and outcomes of DKA in these patients. METHODS: - Patients with COVID-19 were identified from the electronic medical record. DKA was defined by standardized criteria. Proportional hazard regression models were used to determine risk factors for, and mortality from DKA in COVID-19. RESULTS: - Of 2366 patients admitted for COVID-19, 157 (6.6%) patients developed DKA, 94% of whom had antecedent type 2 diabetes, 0.6% had antecedent type 1 diabetes, and 5.7% patients had no prior diagnosis of diabetes. Patients with DKA had increased hospital length of stay and in-patient mortality. Higher HbA1c predicted increased risk of incident DKA (HR 1.47 per 1% increase, 95% CI 1.40-1.54). Risk factors for mortality included older age (HR 1.07 per 5 years, 95% CI 1.06-1.08) and need for pressors (HR 2.33, 95% CI 1.82-2.98). Glucocorticoid use was protective in patients with and without DKA. CONCLUSION: - The combination of DKA and COVID-19 is associated with greater mortality, driven by older age and COVID-19 severity. Twit Text FOAVip Diabetic ketoacidosis and mortality in COVID-19 infection ????Diabetes Metab http://www.kidney.de/pget.php?&tw=1&pmid=34332112 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34332112 #FOAvip English Wikipedia <ref>{{Cite pmid|34332112}}</ref> Diabetic ketoacidosis and mortality in COVID-19 infection #MMPMID34332112 Stevens JS; Bogun MM; McMahon DJ; Zucker J; Kurlansky P; Mohan S; Yin MT; Nickolas TL; Pajvani UB Diabetes Metab 2021[Nov]; 47 (6): 101267 PMID34332112show ga AIM: - Patients with diabetes have increased morbidity and mortality from COVID-19. Case reports describe patients with simultaneous COVID-19 and diabetic acidosis (DKA), however there is limited data on the prevalence, predictors and outcomes of DKA in these patients. METHODS: - Patients with COVID-19 were identified from the electronic medical record. DKA was defined by standardized criteria. Proportional hazard regression models were used to determine risk factors for, and mortality from DKA in COVID-19. RESULTS: - Of 2366 patients admitted for COVID-19, 157 (6.6%) patients developed DKA, 94% of whom had antecedent type 2 diabetes, 0.6% had antecedent type 1 diabetes, and 5.7% patients had no prior diagnosis of diabetes. Patients with DKA had increased hospital length of stay and in-patient mortality. Higher HbA1c predicted increased risk of incident DKA (HR 1.47 per 1% increase, 95% CI 1.40-1.54). Risk factors for mortality included older age (HR 1.07 per 5 years, 95% CI 1.06-1.08) and need for pressors (HR 2.33, 95% CI 1.82-2.98). Glucocorticoid use was protective in patients with and without DKA. CONCLUSION: - The combination of DKA and COVID-19 is associated with greater mortality, driven by older age and COVID-19 severity. |*COVID-19/mortality[MESH] |*Diabetic Ketoacidosis/epidemiology[MESH] |Aged[MESH]Diabetic ketoacidosis and mortality in COVID-19 infection (epmc).pdf DeepDyve Pubget Overpricing